| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Steven L. Hoerter
Also a director
Chairman, President and CEO
Title from the Form 4 dated Nov 10, 2026
|
55 | Not stated | Not reported | |
|
John Smither
Interim Chief Financial Officer
|
73 |
Since 2026
this year
|
Not reported | |
|
Salomon Azoulay
Chief Medical Officer
|
69 |
Since 2024
2 years
|
$1,474,978 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 22, 2026 · updated by the 8-K of Oct 22, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Steven L. Hoerter
Board chair
|
55 |
2025
1 year
|
Independent |
Audit Committee
Science and Medicine Committee
|
ORIC Pharmaceuticals, Inc. | $999,986 | |
|
P. Kent Hawryluk
CEO
|
57 |
2019
7 years
|
Not independent | None stated | None stated | Paid as CEO | |
|
Patrick J. Heron
|
55 |
2020
6 years
|
Independent |
Nominating and Corporate Governance Committee
Compensation Committee · Chair
|
Mirum Pharmaceuticals, Inc. | $220,947 | |
|
Edward T. Mathers
|
66 |
2020
6 years
|
Independent |
Nominating and Corporate Governance Committee
Science and Medicine Committee
|
Rhythm Pharmaceuticals, Inc. | $196,190 | |
|
Tiba Aynechi
|
50 |
2022
4 years
|
Independent |
Audit Committee
Compensation Committee
|
None stated | $200,690 | |
|
Ora Pescovitz
|
69 |
2022
4 years
|
Independent |
Science and Medicine Committee
|
None stated | $198,947 | |
|
Steven Ryder
|
75 |
2024
2 years
|
Independent | None stated | None stated | $194,947 | |
|
Laurie Stelzer
|
58 |
2026
this year
|
Independent |
Compensation Committee
|
Spyre Therapeutics, Inc. | Not stated | |
|
Peter Radovich
Joined Oct 20, 2026
|
- | - | Independent | - | - | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Apr 22, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...